GRI Bio, Inc. 8-K Report: Key Updates and Insights for Investors

Based on the provided XML section from the financial report, here are the key insights extracted:

1. Entity Information:

• Name: GRI Bio, Inc.
• CIK: 0001824293
• State of Incorporation: Delaware (DE)
• SEC File Number: 001-40034
• Tax Identification Number: 82-4369909
• Address: 2223 Avenida de la Playa, Suite 208, La Jolla, CA 92037
• Phone Number: 619-400-1170

2. Report Type:

• Filing Type: 8-K, which is used for reporting significant events that shareholders should know about.

3. Report Dates:

• Filing Date: February 19, 2025
• Period Covered: The report covers the date February 19, 2025.

4. Common Stock Information:

• Type of Security: Common Stock
• Par Value: $0.0001 per share

5. Additional Metadata:

• The XML indicates that this is part of a structured data instance using XBRL (eXtensible Business Reporting Language), which is common for SEC filings to enhance data usability.

Summary Insights:

• GRI Bio, Inc. is a Delaware-based company with a reported significant event or update filed on February 19, 2025, under the 8-K form.
• The company has common stock with a very low par value, which may imply a focus on capital growth rather than traditional dividend-paying profiles.
• The filing conforms to SEC regulations and utilizes XBRL for structured reporting, which facilitates better data analysis and comparison within the industry.

This information is crucial for investors and analysts tracking the company's developments, compliance, and market position.